Kongnakorn, Thitima
Sarri, Grammati
Freitag, Andreas
Marczell, Kinga
Kazmierska, Paulina
Masters, Elizabeth
Pawar, Vivek
Zhang, Xinke
Funding for this research was provided by:
Merck KGaA, Darmstadt, Germany
Article History
Accepted: 2 September 2021
First Online: 1 October 2021
Declarations
:
: This research was sponsored by Merck (CrossRef Funder ID: ExternalRef removed) as part of an alliance between Merck and Pfizer.
: TK, KM, and PK are employees of Evidera, which received funding from Merck and Pfizer to conduct this research. GS and AF were employees of Evidera at the time the research was conducted. EM is an employee of Pfizer. VP and XZ are employees of EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA.
: Search terms used are available in the ESM.
: Not applicable.
: GS, AF, and PK developed the SLR protocol and conducted the search and screening. TK, PK, and KM carried out data extraction and validation. TK, AF, KM, and PK led the development of the manuscript. XZ, VP, and EM provided critical review, expertise, and advice related to the therapeutical area. All co-authors assisted in the written material.